Skip to content
  • About
  • Board
  • News
  • Sign Up
  • Contact

Visit

vjoncology logo
VJHemOnc
Logo
  • Home (current)
  • Diseases
    CLL
    Multiple Myeloma
    Myeloproliferative Neoplasms
    ALL
    AML
    Lymphoma
    View all Diseases
  • Topics
    Transplantation
    Measurable Residual Disease
    CAR-T & Cellular Therapy
    Pharmacy
    Nursing
    Supportive Care
    View all Topics
  • Conferences
    MPN Advances Day
    2019
    iwCAR-T
    2019
    COSTEM
    2019
    ESMO
    2019
    iwCLL
    2019
    IMW
    2019
    View all Conferences
  • Features
  • Podcasts
    • About
    • Board
    • News
    • Sign Up
    • Contact

COMy 2019

The 2019 World Congress on Controversies in Multiple Myeloma (COMy) was held in Paris, France on May 16–18. Experts in the field came together to discuss and debate the latest controversies in the field.

1:25
Coupling imaging and molecular techniques to determine MRD in MM
Elena Zamagni
2:24
MRD and outcome after transplantation
Bruno Paiva
6:41
Supportive care and prophylaxis of the side effects of myeloma drugs
Heinz Ludwig
2:44
Second interim analysis of the EMN02 trial
Michele Cavo
1:11
Treatment options for relapsed myeloma: assessing the need for auto-SCT
Inger Nijhof
2:52
Need for myeloma trials comparing new agents with auto-SCT
Inger Nijhof
1:28
Enhancing immune response in multiple myeloma
Sagar Lonial
2:40
Huge potential for CAR-T therapy in myeloma
Andrew Yee
1:58
With new treatment options in myeloma, is auto-SCT still necessary?
Inger Nijhof
2:54
What is the future for myeloma clinical trials?
Mohamad Mohty
1:20
Beyond KarMMa-2: agents targeting BCMA in MM
Andrew Yee
1:34
BCMA-targeting CAR-T: lessons moving forward
Sagar Lonial
3:10
LYRA findings: frontline CyBorD-Dara for myeloma
Michael O’Dwyer
1:47
International Myeloma Workshop (IMW) 2019
Kenneth Anderson
2:04
Lenalidomide for smoldering myeloma
Vincent Rajkumar
2:10
Proteasome inhibitors-based combinations for elderly MM
Maria-Victoria Mateos
  • 1
  • 2
  • 3
  • 4
  • Next
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Continue

Please enter your details if you would like to receive the latest hemonc news and updates

Sign up
Disease Channels
  • CLL
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • ALL
  • AML
  • Lymphoma
  • View all
Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up
mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJHemOnc logo
The content of VJHemOnc is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy